Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Sep 06, 2023 8:06am
97 Views
Post# 35621423

CEO of Pfizer was right...1 in 3 globally will be afflicted

CEO of Pfizer was right...1 in 3 globally will be afflicted by cancer.   When you have cannabinoid API's with a targeting mechanism to disurpt the PCNA function of cancer cells and their replication then someone like Subo in the Asian region of the world or Mohammed in the Middle East region of the world, both under 50, won't care if the API is based on the cannabis plant, they just want their cancer to go away.  The study was conducted by a member of the BRICS economic bloc.  Part of article below...

Cancer cases soared 79% globally among young adults over past 3 decades: study
Story by Katie Dangerfield •
13h

Asurge in global cancer cases for people under the age of 50 has raised urgent concerns about the shifting landscape of this disease among younger populations, according to new research.
 
The study, published Tuesday in the journal BMJ Oncology, found that in 2019 new cases of early-onset cancers (people aged 15 to 49 years) were 3.26 million, a 79.1-per cent increase from 1990.

While breast cancer made up the highest number of cases in this age group, the fastest-rising cancers since 1990 have been those of the windpipe (nasopharynx) and prostate, the study found.
 
The researchers found that new cancer cases cancer with the heaviest death toll for young adults were breast, windpipe, lung, bowel and stomach.
 
"Cancers historically perceived to be more common in older age groups are now being diagnosed in younger adults, including colorectal, breast, oesophageal, gastric and pancreatic cancers, among others," said Dr. Ashleigh Hamilton, a clinical lecturer at the Centre for Public Health at Queen's University Belfast, U.K., in an editorial piece on the study. She was not involved in the research.
 
"It is important to educate both the public and healthcare professionals regarding the possibility of certain cancers in younger adults to allow earlier diagnosis, which in turn improves outcomes."
 
In order to find the results, the researchers of the study, based in China, used data from the Global Burden of Disease 2019 Study for 29 cancers in 204 countries and regions.

<< Previous
Bullboard Posts
Next >>